Search for Clinical Trial Results

Sponsored By

Sarcoma, Synovial - 20 Studies Found

Status Study
Recruiting Study Name: DHEA in Synovial Sarcoma Patients
Condition:
  • Synovial Sarcoma
  • Sarcoma, Synovial
    Date: 2016-02-11
    Interventions:
    • Drug: DHEA Other Name: Dehydro
Terminated Study Name: First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
Condition: Sarcoma, Synovial
Date: 2011-11-03
Interventions:
  • Drug: OTSA101-DTPA-90Y level 1

Terminated Study Name: A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma
Condition: Synovial Sarcoma
Date: 2005-08-30
Interventions: Drug: Anti-CTLA4 (monoclonal antibody MDX-010)
Recruiting Study Name: A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
Condition: Synovial Sarcoma
Date: 2011-04-26
Interventions: Biological: NY-ESO-1(c259)T Cells Cytoreductive chemotherapy followed by infusion with NY-ESO-1(c259) tr
Recruiting Study Name: Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases
Condition:
  • Synovial Sarcoma
  • Single or Multiple Lung Metastases

Date: 2014-07-02
Interventions: Radiation: Whole Lung IMRT External beam radiation therapy will be administered on an outpatient basis,
Not yet recruiting Study Name: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma
Condition:
  • Alveolar Soft Part Sarcoma
  • Leiomyosarcoma
  • Drug: AL 3818 Other Name: Anlo
Completed Study Name: Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
Condition: Sarcoma
Date: 2005-03-03
Interventions: Biological: trastuzumab
Completed Study Name: Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
Condition: Sarcoma
Date: 2003-01-24
Interventions: Drug: gefitinib
Withdrawn Study Name: NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Condition:
  • Adult Synovial Sarcoma
  • Myxoid/Round Cell Liposarcoma
  • Date: 2014-02-07
    Interventions:
    • Biological: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes

Recruiting Study Name: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Condition:
  • Rhabdoid Tumors
  • INI1-negative Tumors
  • Date: 2015-10-21
    Interventions: Drug: Tazemetostat Tazemetostat (EPZ-6438) is a selective small molecule inhibitor of the histone-lysine
Next >>>